Safety and efficacy of preoperative combination therapy of chemotherapy and hyperbaric oxygen therapy for resectable pancreatic cancer
Not Applicable
Recruiting
- Conditions
- Resectable pancreatic cancer
- Registration Number
- JPRN-UMIN000049855
- Lead Sponsor
- Division of Surgery National Hospital Organization Higashi-Ohmi General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
1) pulmonary fibrosis or interstitial pneumonitis 2) frequent watery diarrhea that is resistant to treatment 3) active double cancer 4) distant metastasis 5) R2 resection 6) prior anti-cnacer therapy 7) pregnancy 8) a history of spontaneous pneumothorax, bronchial asthma, open-heart surgery, etc., and who are at risk of acute ventilation failure 9) ophthalmic treatment/after surgery (when intraocular pressure gas C3F8, SF6 is used for retinal detachment, etc.) 10) Difficult to tolerate radical surgery 11) Have an active infectious disease (fever 38.0 degrees or higher) 12) those who do not have sufficient judgment to obtain consent for this research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 year relapse-free survival
- Secondary Outcome Measures
Name Time Method Adverse effect Dose intensity Resectability rate Pathological effect Tumor marker Tumor volume Form of recurrence